Home › Overweight › Florida › Ocala
Overweight clinical trials in Ocala, FL
6 studies for Overweight are looking for participants at sites in and around Ocala (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RecruitingPhase 3
- Renstar Medical Research, Ocala
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
RecruitingPhase 2
- Renstar Medical Research, Ocala
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
RecruitingPhase 3Healthy volunteers welcome
- ACCOMPLISH-2 Research Site, Ocala
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
RecruitingPhase 3
- Renstar Medical Research, Ocala
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
RecruitingPhase 3
- Renstar Medical Research, Ocala
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
RecruitingPhase 3
- ACCOMPLISH-1 Research Site, Ocala
Overweight trials in other cities
- Houston, TX33 studies
- San Antonio, TX33 studies
- Chicago, IL28 studies
- Orlando, FL25 studies
- Las Vegas, NV23 studies
- Miami, FL23 studies
- Dallas, TX20 studies
- Atlanta, GA20 studies
- Jacksonville, FL19 studies
- Washington, DC19 studies
- New York City, NY19 studies
- Austin, TX18 studies
Other studies in Ocala
- Non-Small Cell Lung Cancer10 studies
- Obesity7 studies
- Steatotic Liver Disease7 studies
- Alzheimer's Disease6 studies
- Heart Failure5 studies
- COPD5 studies
- Metastatic Cancer3 studies
- Mild Cognitive Impairment3 studies
- Chronic Pain3 studies
- Atherosclerosis3 studies
- Cardiovascular Disease3 studies
- Liver Diseases3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.